The Multiplex PCR Assays Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for multiplex pcr assays has experienced swift expansion in the past few years. The market value ascended from $1.51 billion in 2024 to $1.72 billion in 2025. This represents a compound annual growth rate (CAGR) of 13.6%.
The Multiplex PCR Assays market is projected to reach a market size of $2.83 billion in 2029, growing at a compound annual growth rate (CAGR) of 13.4%.
Download Your Free Sample of the 2025 Multiplex PCR Assays Market Report and Uncover Key Trends Now!The drivers in the multiplex pcr assays market are:
• Increased prevalence of infectious diseases
• Rising governmental funding and support
• Growing use in clinical diagnostics and personalized medicine
• Advancements in bioinformatics and data analysis tools
The multiplex pcr assays market covered in this report is segmented –
1) By Assay Type: Planar Assay, Bead Based Assay
2) By Product And Services: Consumables, Instruments, Software And Services
3) By Application: Disease Diagnosis, Research And Development, Other Applications
4) By End User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users
The trends in the multiplex pcr assays market are:
• The integration of next-generation sequencing (NGS) in multiplex PCR assays is a key emerging trend.
• Companion diagnostics, digital PCR technology, automation and high-throughput systems are also shaping the market.
• The industry is also moving towards more point-of-care and portable devices along with increasing customization and multiplexing capabilities.
• Adoption of artificial intelligence and machine learning, enhanced data management and cloud solutions are other significant trends in this market.
The major players in the multiplex pcr assays market are:
• F. Hoffmann-La Roche Ltd.
North America was the largest region in the multiplex PCR assays market in 2024